Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2024

TCT 706: One-Year Pooled Outcomes of Transcatheter Arterialization of the Deep Veins From the PROMISE I, II, and UK Studies

Presenter: Mehdi Shishehbor

October 30, 2024

Presentation TCT 2024

BTK and BTA: How is Promise II and DVA Making an impact?

Presenter: Anahita Dua

October 28, 2024

Presentation TCT 2024

One-Year Clinical Outcomes and Long-term Cost-Effectiveness Using Propensity-Score Matching of Pooled PROMISE Studies and the CLariTI Registry for No-Option CLTI Patients

Presenter: Richard Powell

October 28, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

Presentation TCT 2018

Percutaneous Deep Vein aRterialization for the Treatment of Late Stage Critical LiMb ISchEmia, The PROMISE Trial: Early Feasibility Interim Results (LimFlow)

Presenter: George L Adams, Tony Das, Steve Henao

September 21, 2018

Advertisement

TCT 706: One-Year Pooled Outcomes of Transcatheter Arterialization of the Deep Veins From the PROMISE I, II, and UK Studies

BTK and BTA: How is Promise II and DVA Making an impact?

One-Year Clinical Outcomes and Long-term Cost-Effectiveness Using Propensity-Score Matching of Pooled PROMISE Studies and the CLariTI Registry for No-Option CLTI Patients

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Percutaneous Deep Vein aRterialization for the Treatment of Late Stage Critical LiMb ISchEmia, The PROMISE Trial: Early Feasibility Interim Results (LimFlow)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content